Events

07 Apr 2021

Press briefing on the conclusion of the assessment of the Pharmacovigilance Risk Assessment Committee (PRAC) of Vaxzevria (previously COVID-19 Vaccine AstraZeneca) and thromboembolic events

Online

European Medicines Agency, Amsterdam, the Netherlands

Start date: 7 April 2021

End date: 7 April 2021

EventHumanCOVID-19Vaccines

06 Apr 2021

Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 April 2021

European Medicines Agency, Amsterdam, the Netherlands

Start date: 6 April 2021

End date: 6 April 2021

EventHumanPharmacovigilance

31 Mar 2021

First Nitrosamine Implementation Oversight Group (NIOG) - meeting with pharmaceutical industry

European Medicines Agency, Amsterdam, the Netherlands

Start date: 31 March 2021

End date: 31 March 2021

Event

30 Mar 2021

Webinar on reporting suspected side effects following administration of veterinary medicines

Online

European Medicines Agency, Amsterdam, the Netherlands

Start date: 30 March 2021

End date: 30 March 2021

EventVeterinaryPharmacovigilance

26 Mar 2021

Public stakeholder meeting: approval, safety monitoring and impact of COVID-19 vaccines in the EU

Online

European Medicines Agency, Amsterdam, the Netherlands

Start date: 26 March 2021, 13:00 (CET)

End date: 26 March 2021, 15:15 (CET)

EventHumanCOVID-19

25 Mar 2021

European Medicines Agency / AnimalhealthEurope veterinary medicines info day 2021

Online

European Medicines Agency, Amsterdam, the Netherlands

Start date: 25 March 2021

End date: 25 March 2021

EventVeterinaryResearch and developmentScientific advice

23 Mar 2021

Paediatric Committee (PDCO): 23-26 March 2021

Online

European Medicines Agency, Amsterdam, the Netherlands

Start date: 23 March 2021

End date: 23 March 2021

EventHumanPaediatrics

22 Mar 2021

Committee for Medicinal Products for Human Use (CHMP): 22-25 March 2021

European Medicines Agency, Amsterdam, the Netherlands

Start date: 22 March 2021

End date: 22 March 2021

EventHumanMedicines

18 Mar 2021

Extraordinary meeting of the Pharmacovigilance Risk Assessment Committee (PRAC): 18 March 2021

Online

European Medicines Agency, Amsterdam, the Netherlands

Start date: 18 March 2021

End date: 18 March 2021

EventHumanCOVID-19Pharmacovigilance

18 Mar 2021

Press briefing on the conclusion of the investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events by the Pharmacovigilance Risk Assessment Committee (PRAC)

Online

European Medicines Agency, Amsterdam, the Netherlands

Start date: 18 March 2021

End date: 18 March 2021

EventHumanCOVID-19Vaccines

Filter by

Past events (3078)